CONTI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 6.465
EU - Europa 3.023
AS - Asia 1.016
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 4
OC - Oceania 3
Totale 10.548
Nazione #
US - Stati Uniti d'America 6.345
DE - Germania 657
IT - Italia 633
CN - Cina 442
SE - Svezia 365
IE - Irlanda 359
SG - Singapore 248
RU - Federazione Russa 222
UA - Ucraina 207
GB - Regno Unito 193
AT - Austria 121
CA - Canada 119
HK - Hong Kong 115
FI - Finlandia 90
IN - India 68
DK - Danimarca 62
TR - Turchia 54
FR - Francia 38
VN - Vietnam 38
BE - Belgio 35
BR - Brasile 15
ID - Indonesia 15
KR - Corea 14
CZ - Repubblica Ceca 13
EU - Europa 13
NL - Olanda 11
IR - Iran 10
JP - Giappone 8
CH - Svizzera 4
PE - Perù 4
RO - Romania 4
AU - Australia 3
CL - Cile 3
EG - Egitto 2
PL - Polonia 2
PT - Portogallo 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
ES - Italia 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MC - Monaco 1
MX - Messico 1
NO - Norvegia 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 10.548
Città #
Ann Arbor 2.175
Chandler 534
Woodbridge 522
Frankfurt am Main 419
Wilmington 375
Dublin 348
Houston 328
Fairfield 298
Jacksonville 265
Ashburn 251
Dearborn 250
Milan 209
Singapore 172
New York 153
Seattle 134
Princeton 130
Vienna 121
Hong Kong 114
Cambridge 106
Nanjing 95
Shanghai 75
Boardman 54
Lachine 51
Lawrence 36
Brussels 34
Nanchang 33
Beijing 32
Dong Ket 30
Helsinki 29
Santa Clara 28
Guangzhou 27
Ottawa 27
Pune 24
Rome 24
Shenyang 23
Fremont 22
Altamura 21
San Diego 20
Tianjin 19
Andover 18
Falls Church 18
Carate Brianza 17
Norwalk 16
Jakarta 15
Jiaxing 15
Toronto 15
Dallas 14
Edmonton 14
Hebei 14
Monza 13
Brno 12
Changsha 12
Jinan 12
Ningbo 12
Kunming 11
Mountain View 11
Zhengzhou 11
Leawood 10
Lissone 10
London 10
Detroit 9
Los Angeles 9
Monmouth Junction 9
Munich 8
Taizhou 8
Lappeenranta 7
Gaziantep 6
Hangzhou 6
Hefei 6
Lecco 6
Pisa 6
Rozzano 6
São Paulo 6
Vadodara 6
Bergamo 5
Bonn 5
Busto Arsizio 5
Como 5
Daejeon 5
Grafing 5
Nürnberg 5
Redmond 5
Rho 5
Ripalta Cremasca 5
Verona 5
Bologna 4
Desio 4
Fuzhou 4
Haikou 4
Huizen 4
Lima 4
Melegnano 4
Misinto 4
Napoli 4
San Mateo 4
Verdellino 4
Washington 4
Auburn Hills 3
Boisbriand 3
Bonndorf 3
Totale 8.098
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 390
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents 336
QT interval and dispersion in drug-free anorexia nervosa adolescents: a case control study 331
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 283
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 278
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 274
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 273
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer's disease 257
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 252
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 248
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 236
Anorexia nervosa in adolescent girls and celiac disease serology 234
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 233
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 231
The one-carbon metabolism in anorexia nervosa of the restrictive type 224
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 216
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 214
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 205
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 192
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 188
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 182
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 178
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 175
Behavioural anomalies in neurodegenerative diseases: role of the immune response 170
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa. 167
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 160
Anorexia nervosa of the restrictive type and celiac disease in adolescence 160
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 159
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 157
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 155
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 154
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type 152
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 150
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 149
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression 144
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor 144
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 143
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 142
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types 142
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity 142
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 137
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study 131
Affective states and pathology in adolescents with borderline personality 130
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 127
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 125
Erk signalling modulates app metabolism, tau phosphorylation and eaat1 processing in fibroblasts from alzheimer’s patients 123
the MonzALS collaborative network 122
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 119
Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response 117
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome 116
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 116
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid 114
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 109
Whole-blood global DNA methylation and phenotypic variability in ALS 106
New insights into the genetic etiology of Alzheimer's disease and related dementias 106
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 103
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 99
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 96
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study 96
Further ex vivo evidence for a role of donepezil in the modulation of the immune response 95
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease 95
Blood-based biomarkers of neuroinflammation in alzheimer’s disease: A central role for periphery? 91
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 90
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors 87
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 86
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 78
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 58
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 50
Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients 42
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review 24
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 23
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 21
Totale 11.252
Categoria #
all - tutte 32.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.453 0 0 110 103 154 216 298 113 144 140 152 23
2020/20211.970 127 82 204 248 186 162 201 148 166 178 102 166
2021/20221.111 139 145 124 110 71 67 55 50 48 61 85 156
2022/20231.924 192 525 218 207 131 281 36 108 129 25 44 28
2023/20241.311 62 60 71 66 161 323 233 46 59 23 18 189
2024/2025449 171 277 1 0 0 0 0 0 0 0 0 0
Totale 11.252